BibTex RIS Cite

İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi

Year 2011, Volume: 4 Issue: 1, - , 01.03.2011

Abstract

Türkçe Özet: Amaç: Dokuların yeterli oksijenlenmesi için hemoglobin konsantrasyonu önemlidir. Hemoglobin düzeylerindeki düşüklükler dokuların radyosensitivitesini azaltıyor olabilir. Çalışmada ileri evre kanser olgularında hemoglobin düzeylerinin, öncellikle radyoterapi veya radyoterapi+kemoterapiye verilen yanıtla ilişkisinin olup olmadığının gösterilmesi amaçlandı. Yöntem: Mayıs 1997-Mayıs 1998 tarihleri arasında Çukurova Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı\'nda radyoterapi uygulanan ileri evre 61 olguda hemoglobin düzeylerinin radyoterapi veya radyoterapi+kemoterapiye verilen yanıt ilişkisi prospektif olarak değerlendirildi. Hemoglobin düzeylerinin ölçümleri, tedavinin başlangıcında (I. kontrol), ortasında (II. kontrol), bitiminde (III. kontrol) ve tedaviden sonraki 3. ayda (IV. kontrol) yapıldı. Bulgular: Primer tümör ve lenfatik metastazlarına Co 60 cihazıyla radyoterapi verilen olgularda tedaviye yanıt oranı %27.8 idi. Olgulardan %11.4'ünde tam yanıt, %16.4'ünde kısmi yanıt, %47.6'sında stabil hastalık, %24.6'sında ilerleme saptandı. Olguların 25'ine kemoterapi ve radyoterapi birlikte uygulandı (%40.9). Tedavi yanıtlarına göre gruplar arasında hemoglobin düzeyleri açısından farklılık anlamlı bulundu (p<0.001). Tam yanıt+kısmi yanıt grubu ve stabil hastalık grubu ile ilerleme gösteren grup arasında hemoglobin düzeyleri açısından farklılık anlamlı bulundu (p<0.001). Sonuç: Aneminin, artmış lokal rekürrens ve kısalmış sürvi oranları ile birlikte olduğu belirlendi. Kanserli olgularda radyoterapi veya radyoterapi+kemoterapi uygulanırken aneminin izlenmesinin ve düzeltilmesinin tedavi etkinliğini artırabileceği düşünüldü.

References

  • Todd HW, Chapman JD. Radiation response modulation. In:
  • Perez CA. Brady LW. Halpcrin E.C. Schmidt—Ulrich RK. eds.
  • Principles and Practice of Radiation Oncology. Philcdelphia:
  • Lippincott Williams Jr. Wilkins.2üü4:663-98.
  • Harrison LB. Shasha D. Homel P. Prevalcnce of anemia in
  • cancer patients undergoing radiotherapy: prognostic
  • significance and treatment. Oncology 2002630): l [-8.
  • Vaupel P. Mayer A. Hypoxia and anemia: effects on tumor
  • biology and treatment resistance. Transfers Clin Biol 1005;I2t|):5-I0.
  • Vaupel P. 'I'hews 0. Hoeckel M. Treatment resistance of
  • solid tumors: role of hypoxia and anemia. Med Oncel
  • C)Ül;llll4):243-59.
  • Harrison L. Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Onmlogist 2004 '.5(9):3 l—4Ü.
  • Harrison LB. Chadha M, Hill RJ. Hu [(. Shasha D. impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002:7(6):492-508.
  • Birgegard G. Aapro MS. Bokemeycr C. Dicato M. Drings P .Hamedo J. Kızakowski M. Ludwing H. Pecorelli S. Schmoll H. Schneider M. Schı'ijvers D. Shasha D. Van Belle S. Cancer—related anemia: pathogenesis. prevalence and treatment. Oncology 20:15:68“ ];3—I ].
  • Haugen H. Magnusson B. Svensson M. Mcrcke C. Preradiotherapy hemoglobin level but not microvessel density predicts loeoııegional control and survival in laryngeal cancer treated with primary radical radiotherapy. Clin Cancer Res 2004“. I (KB)???“ J).
  • Schafer U. Micke O., Muller SB. Schuller P. Willich N. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. .S'rmhlenrher Onkoı' 2003; 1 îMSlüğî—îfi.
  • Robnett 't'J. Maelıtay M. Hahn SM. Shrager JB. Friedberg .IS, Kaiser LR. Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients. Cancer . 2002:8t3]ı:263ı7.
  • Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncel ZUÜI ;3[2):bU-5.
  • Muostedt K. Vol-ring M. Von Georgi R. Hemoglobin levels during radiation therapy and their influence on local control and survival of patients with eıtdome1rial carcinoma. Dnr—ol Rep ?.004;l l(3):?l l-T.
  • Quilty PM. Duncan W. The inşuence of hemoglobin level on the regression anıl long terra local control of transitional cell carcinoma ol' the bladder following photon irradiation. lnr J' Radial Onca Biol Fifty: teaming): IMS—42.
  • Altun M. Demiral AN. Meral R. Kaytan F.. Cesar R. Disci R. Dizdar Y. Prognostic signiŞcance of hemoglobin concentration in nasopharyngcal carcinoma: dee.—t treatment-induced anemia have negative effect? In Vivo 2003: “(S):-1833.

İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi

Year 2011, Volume: 4 Issue: 1, - , 01.03.2011

Abstract

AbstractRelationship of Haemoglobin Levels with Response to Radiotherapy and Chemotherapy in Advanced Cancer Cases Aim: Haemoglobin concentration is important for sufficient oxygenisation of tissues. Low levels of haemoglobin might decrease radiosensitivity of tissues. In this study, it was primarily aimed to evaluate a potential relationship between haemoglobin levels and response to the radiotherapy or the combined treatment with radiotherapy + chemotherapy in advanced cancer cases. Methods: Relationship among haemoglobin levels with response to radiotherapy or radiotherapy+chemotherapy were evaluated prospectively in 61 advanced cancer cases at Çukurova University, Medical School, Department of Radiation Oncology from May 1997 to May 1998. Measurement of haemoglobin levels were performed in the beginning (lst control), in the middle (2nd control), in the end of the therapy (3rd control) and 3 months after the therapy (4th control). Results: Response to therapy rate of cases which had radiotherapy with Co 60 for primary tumor and lymphatic metastases were 27.8%. It is found that complete response in 11.4%, partial response in 16.4%, stable in 47.6% and progression in 24.6% of cases. Chemotherapy and radiotherapy performed to 25 of cases (40.9%). As regarding responses to the therapy, differences in haemoglobin levels between groups were found significant (p<0.001). Conclusion: It was determined that anemia is associated with increased local recurrens and shortened survey rates. It was suggested that monitoring and improvement of anemia during the radiotherapy or the combination treatment of radiotherapy with chemotherapy in cancer cases might improve the efficiency of the treatment.

References

  • Todd HW, Chapman JD. Radiation response modulation. In:
  • Perez CA. Brady LW. Halpcrin E.C. Schmidt—Ulrich RK. eds.
  • Principles and Practice of Radiation Oncology. Philcdelphia:
  • Lippincott Williams Jr. Wilkins.2üü4:663-98.
  • Harrison LB. Shasha D. Homel P. Prevalcnce of anemia in
  • cancer patients undergoing radiotherapy: prognostic
  • significance and treatment. Oncology 2002630): l [-8.
  • Vaupel P. Mayer A. Hypoxia and anemia: effects on tumor
  • biology and treatment resistance. Transfers Clin Biol 1005;I2t|):5-I0.
  • Vaupel P. 'I'hews 0. Hoeckel M. Treatment resistance of
  • solid tumors: role of hypoxia and anemia. Med Oncel
  • C)Ül;llll4):243-59.
  • Harrison L. Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Onmlogist 2004 '.5(9):3 l—4Ü.
  • Harrison LB. Chadha M, Hill RJ. Hu [(. Shasha D. impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002:7(6):492-508.
  • Birgegard G. Aapro MS. Bokemeycr C. Dicato M. Drings P .Hamedo J. Kızakowski M. Ludwing H. Pecorelli S. Schmoll H. Schneider M. Schı'ijvers D. Shasha D. Van Belle S. Cancer—related anemia: pathogenesis. prevalence and treatment. Oncology 20:15:68“ ];3—I ].
  • Haugen H. Magnusson B. Svensson M. Mcrcke C. Preradiotherapy hemoglobin level but not microvessel density predicts loeoııegional control and survival in laryngeal cancer treated with primary radical radiotherapy. Clin Cancer Res 2004“. I (KB)???“ J).
  • Schafer U. Micke O., Muller SB. Schuller P. Willich N. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. .S'rmhlenrher Onkoı' 2003; 1 îMSlüğî—îfi.
  • Robnett 't'J. Maelıtay M. Hahn SM. Shrager JB. Friedberg .IS, Kaiser LR. Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients. Cancer . 2002:8t3]ı:263ı7.
  • Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncel ZUÜI ;3[2):bU-5.
  • Muostedt K. Vol-ring M. Von Georgi R. Hemoglobin levels during radiation therapy and their influence on local control and survival of patients with eıtdome1rial carcinoma. Dnr—ol Rep ?.004;l l(3):?l l-T.
  • Quilty PM. Duncan W. The inşuence of hemoglobin level on the regression anıl long terra local control of transitional cell carcinoma ol' the bladder following photon irradiation. lnr J' Radial Onca Biol Fifty: teaming): IMS—42.
  • Altun M. Demiral AN. Meral R. Kaytan F.. Cesar R. Disci R. Dizdar Y. Prognostic signiŞcance of hemoglobin concentration in nasopharyngcal carcinoma: dee.—t treatment-induced anemia have negative effect? In Vivo 2003: “(S):-1833.
There are 22 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Hasan Suat Arslantaş This is me

Candaş Tunalı This is me

Gülhan Orekici Temel This is me

Publication Date March 1, 2011
Submission Date June 13, 2014
Published in Issue Year 2011 Volume: 4 Issue: 1

Cite

APA Arslantaş, H. S., Tunalı, C., & Temel, G. O. (2011). İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi. Mersin Üniversitesi Sağlık Bilimleri Dergisi, 4(1).
AMA Arslantaş HS, Tunalı C, Temel GO. İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi. Mersin Univ Saglık Bilim derg. March 2011;4(1).
Chicago Arslantaş, Hasan Suat, Candaş Tunalı, and Gülhan Orekici Temel. “İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi Ve Kemoterapiye Verilen Yanıtla İlişkisi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 4, no. 1 (March 2011).
EndNote Arslantaş HS, Tunalı C, Temel GO (March 1, 2011) İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi. Mersin Üniversitesi Sağlık Bilimleri Dergisi 4 1
IEEE H. S. Arslantaş, C. Tunalı, and G. O. Temel, “İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi”, Mersin Univ Saglık Bilim derg, vol. 4, no. 1, 2011.
ISNAD Arslantaş, Hasan Suat et al. “İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi Ve Kemoterapiye Verilen Yanıtla İlişkisi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 4/1 (March 2011).
JAMA Arslantaş HS, Tunalı C, Temel GO. İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi. Mersin Univ Saglık Bilim derg. 2011;4.
MLA Arslantaş, Hasan Suat et al. “İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi Ve Kemoterapiye Verilen Yanıtla İlişkisi”. Mersin Üniversitesi Sağlık Bilimleri Dergisi, vol. 4, no. 1, 2011.
Vancouver Arslantaş HS, Tunalı C, Temel GO. İleri Evre Kanserli Olgularda Hemoglobin Düzeylerinin Radyoterapi ve Kemoterapiye Verilen Yanıtla İlişkisi. Mersin Univ Saglık Bilim derg. 2011;4(1).

MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.

Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.

Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.

Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.

Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.

Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.

154561545815459

Creative Commons Lisansı
This work is licensed with Attribution-NonCommercial 4.0 International.